CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice
about
HBV induced HCC: major risk factors from genetic to molecular level4-1BB Agonists: Multi-Potent Potentiators of Tumor ImmunityInterleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in miceInduction of regulatory T cells by high-dose gp96 suppresses murine liver immune hyperactivation.Memory CD8+ T cells are sufficient to alleviate impaired host resistance to influenza A virus infection caused by neonatal oxygen supplementation.Clinical targeting of the TNF and TNFR superfamiliesAdvances in targeting cell surface signalling molecules for immune modulationHuman and mouse CD137 have predominantly different binding CRDs to their respective ligandsInterleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice.Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitmentT-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy.The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review).Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.Up-regulation of brain-expressed X-linked 2 is critical for hepatitis B virus X protein-induced hepatocellular carcinoma development.Complete coding sequence and molecular analysis of hepatitis A virus from a chimpanzee with fulminant hepatitis.Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model.S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity.
P2860
Q26825274-1EDFF96F-81FD-4917-B65C-3841E9E04381Q27012963-5879449B-50E6-40C0-B340-33D357986576Q33843364-B82491BE-E1EC-44AA-9DF1-3E7F69C5BF1FQ34852383-B289C232-72F8-47FC-85ED-BFCA06705409Q36191671-C3E082CD-E63A-4734-ADE0-F88E4913A01CQ36762882-A9943640-E34B-4009-92CB-DD37A92989B6Q36973787-2BA675F6-EAC7-47FF-AAD7-D4A636B88274Q37500368-B95242AD-AFC0-407B-86E2-6D6DC074EFCAQ37530484-4C665C9E-ADA3-45E0-ACC9-E45B1A4E2F7FQ37673234-ED47070E-452A-436A-A997-8CC36701A7C9Q37948129-7CD5640F-BADC-4148-8FDE-D34268614550Q38129083-A0C1F5A2-F1C6-4B67-B103-7579C6237E05Q39450245-68752AF3-1BBD-4F6C-A28F-F6C5B2C87F3AQ41543718-10E2259A-D78E-4684-AEFC-B9C7049E1DDFQ42371584-50683BC0-693E-4EB1-9BD3-1BCD7A0F39E0Q45362245-4550168E-BBEC-44F5-9E89-1D48AA6628ACQ47132620-7C53114D-B319-48FE-8647-F511D56DA9EEQ52597566-C64728CB-EAEE-49E4-BAF6-E9EC747F411B
P2860
CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
CD137-mediated pathogenesis fr ...... atitis B virus-transgenic mice
@ast
CD137-mediated pathogenesis fr ...... atitis B virus-transgenic mice
@en
type
label
CD137-mediated pathogenesis fr ...... atitis B virus-transgenic mice
@ast
CD137-mediated pathogenesis fr ...... atitis B virus-transgenic mice
@en
prefLabel
CD137-mediated pathogenesis fr ...... atitis B virus-transgenic mice
@ast
CD137-mediated pathogenesis fr ...... atitis B virus-transgenic mice
@en
P2093
P2860
P356
P1476
CD137-mediated pathogenesis fr ...... atitis B virus-transgenic mice
@en
P2093
Dongling Li
Liang Cheng
Lieping Chen
Mingzhou Guo
Shengdian Wang
Wenxia Zhao
Xiaozhu Li
P2860
P304
P356
10.4049/JIMMUNOL.1000927
P407
P577
2010-11-08T00:00:00Z